VISEN Pharmaceuticals (HKG:2561)
Hong Kong · Delayed Price · Currency is HKD 18.53
-0.28 (-1.49%)
Oct 9, 2026, 11:22 AM HKT
VISEN Pharmaceuticals Market Cap
VISEN Pharmaceuticals has a market cap or net worth of 2.03 billion as of October 9, 2026. It is the 19,386th most valuable company in the world and the 862nd biggest in Hong Kong. Its market cap has decreased by 55.98% in one year.
Market Cap
2.03B
Enterprise Value
1.65B
Revenue
39.32M
Global Rank
Country Rank
#862 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since March 21, 2025, VISEN Pharmaceuticals's market cap has decreased from 7.20B to 2.03B, a decrease of -71.73%. That is a compound annual growth rate of -55.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 2.03B | -40.95% |
| Dec 31, 2025 | 3.44B | -52.13% |
| Mar 21, 2025 | 7.20B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xuanzhu Biopharmaceutical | 4.34B |
| Edding Genor Group Holdings | 3.36B |
| CF PharmTech | 2.46B |
| Hua Medicine (Shanghai) | 2.23B |
| CPBIO Holding Company | 2.01B |
| Jacobson Pharma Corporation | 1.94B |
| Dawnrays Pharmaceutical (Holdings) | 1.45B |
| Golden Throat Holdings Group Company | 1.42B |